T. Tamura et al. / Bioorganic & Medicinal Chemistry xxx (2017) xxx–xxx
7
1.62 (2 s, 6H, CMe2), 3.52–3.64 (m, 2H, H50), 4.36–4.41 (m, 1H, H40),
5.06 (dd, 1H, J = 3.3, 6.3 Hz, H30), 5.46 (dd, 1H, J = 2.5, 6.5 Hz, 2H0),
5.89 (br, 2H, NH2), 6.11 (d, 1H, J = 2.5 Hz, H10), 7.93 (s, 1H, H8), 8.36
(s, 1H, H2). ESI-TOF-MS for C13H16N8O3: (MNa+) calcd: 355.12,
found: 355.08.
Ar-H), 7.79 (d, J = 9.5 Hz, 1H, Ar-H), 8.01 (s, 1H, H8), 8.30 (s, 1H,
H2), 8.82 (d, J = 7.0 Hz, 1H, NH); ESI-TOF-MS for C23H22N6O8:
(MH+) calcd: 511.16, found: 511.09.
4.4. Determination of the binding affinity of Umb-Ado to RNP by
fluorescence titrations
4.3.3. Synthesis of 50-deoxy-50-amino-20,30-O-isopropylideneadenosine
429
The fluorescence measurements were performed using 96-well
plates on a Wallac ARVOsx 1420 multilabel counter or Tecan infin-
ity pro for the determination of the binding affinity of Umb-Ado to
RNP. A binding solution (100 mL) containing 1 mM of fluorescent
RNP (An15/5FAM-Rev) in 30 mM Bis-Tris-HCl (pH 6.0), 100 mM
NaCl, 5 mM MgCl2, and 0.005% Tween 20 with indicated concentra-
tion of substrate was gently swirled for few minutes and allowed
to settle for 30 min at 20 °C. Emission spectra were measured with
an appropriate filter set for each fluorophore. Excitation and emis-
sion wavelengths for 5FAM-Rev were 485 and 535 nm, respec-
tively. The binding affinity of fluorescent RNP to Umb-Ado was
obtained by fitting the substrate titration data using the equation:
Compound 3 (1.0 g, 3.3 mmol) and 10% Pd/C (200 mg) in metha-
nol (50 mL) were stirred in room temperature under hydrogen
atmosphere. After 4 h, the reaction mixture was filtered. This
resulting mixture containing compound 4 was used in the next
step without further purification. 1H NMR (300 MHz, CDCl3) d
1.41 and 1.64 (2 s, 6H, CMe2), 3.01–3.07 (m, 2H, H50), 4.30–4.31
(m, 1H, H40), 5.05 (dd, J = 6.3, 3.3 Hz, 1H, H30), 5.48 (dd, J = 6.3,
3.0 Hz, 1H, H20), 6.12 (d, J = 3.0 Hz, 1H, H10), 8.18 (s, 1H, H2), 8.82
(s, 1H, H8); ESI-TOF-MS for C13H16N8O3: (MNa+) calcd: 307.14,
found: 307.11.
4.3.4. Synthesis of 50-deoxy-50-(300-carboxypropyl) amido-20,30-O-
isopropylideneadenosine 5
ꢀ
Fobs ¼ A ð½FRNPꢃT þ ½substrateꢃT þ KDÞ
2
Compound 4 (313 mg, 1.02 mmol) and succinic anhydride
(795 mg, 7.5 mmol) were stirred in distilled pyridine (20 mL)
under the nitrogen atmosphere at 0 °C. The temperature was
increased to room temperature over 30 min. After 12 h, the organic
layer was washed with hydrochloric acid, conc. sodium bicarbon-
ate, brine and then dried over anhydrous sodium sulfate to give
compound 5 (230 mg, 0.57 mmol, 56%). 1H NMR (300 MHz, CDCl3)
d 1.35 and 1.69 (2 s, 6H, CMe2), 2.78–2.84 (m, 4H, (CH2)2), 3.23 (d,
J = 14.7 Hz, 1H, H50), 3.64–3.76 (m, 2H, NH2), 4.20–4.28 (m, 1H,
H50), 4.52 (d, J = 2.1 Hz, 1H, H40), 4.78 (dd, J = 6.3, 1.8 Hz, 1H,
H30), 5.30 (m, 1H, H20), 5.78 (d, J = 5.4 Hz, 1H, H10), 7.87 (s, 1H,
H2), 8.31 (d, J = 9.6 Hz, 1H, NH), 8.38 (s, 1H, H8); ESI-TOF-MS for
ꢁðð½FRNPꢃT þ ½substrateꢃT þ KDÞ
o
1=2
ꢁ4½FRNPꢃT½substrateꢃTÞ
=2 ½FRNPꢃT
where A is the increase in fluorescence at saturating substrate con-
centrations (Fmax ꢁ Fmin), KD is the equilibrium dissociation con-
stant, and [FRNP]T and [substrate]T are the total concentrations of
fluorescent RNP and the substrate, respectively.
4.5. Screening of RNP library
Fluorescence measurements in 96-well plates were performed
on a Wallac ARVOsx 1420 multilabel counter. A solution (100 lL)
C
17H22N6O6: (MH+) calcd: 407.17, found: 407.09.
containing 5 mM of each combination of RNPs and 20 mM Umb-
Ado in reaction buffer containing 30 mM Bis-Tris-HCl (pH 6.0),
100 mM NaCl, 5 mM MgCl2, and 0.005% Tween 20 was gently
swirled for 30 s and the time-dependent emission intensity of
the umbelliferone, which is a product of the hydrolysis, was mea-
sured every 20 min for 3 h. Excitation and emission wavelengths
for umbelliferone were 355 and 455 nm, respectively. Concentra-
tion of the umbelliferone was estimated by using a standard curve.
4.3.5. Synthesis of 50-deoxy-50-(umbelliferyl butylate)amido-20,30-O-
isopropylideneadenosine 6
Compound 5 (28 mg, 0.07 mmol), and umbelliferone (57 mg,
0.35 mmol) were stirred in dichloromethane (15 mL) under nitro-
gen atmosphere at 0 °C. DMAP (0.86 mg, 0.007 mmol) and
WSCIꢂHCl (16 mg, 0.084 mmol) were added and the reaction tem-
perature was increased to room temperature over 30 min. After
24 h, the resulting solution was evaporated and purified by HPLC
(column: 5C18-AR-II 20 mm ꢀ 150 mm/mobile phase 5% acetic
acid with 24–48% acetonitrile) to give compound 6 (0.011 mmol,
16%). 1H NMR (300 MHz, CDCl3) d 1.18 and 1.58 (2 s, 6H, CMe2),
2.69–2.75 (m, 1H, H50), 2.86–2.95 (m, 2H, H80), 3.16–3.25 (m, 2H,
H90), 4.24–4.32 (m, 1H, H50), 4.51 (d, J = 1.9 Hz, 1H, H40), 4.78 (dd,
J = 6.2, 1.9 Hz, 1H, H30), 5.31 (t, J = 5.7 Hz, 1H, H20), 5.74–5.78 (b,
3H, H10 and NH2), 6.34 (d, J = 9.4 Hz, 1H, Ar-H), 7.06 (dd, J = 8.5,
2.2 Hz, 1H, Ar-H), 7.13 (d, J = 2.2 Hz, 1H, Ar-H), 7.44 (d, J = 8.5 Hz,
1H, Ar-H), 7.67 (d, J = 9.6 Hz, 1H, Ar-H), 7.84 (s, 1H, H8), 8.36 (s,
1H, H2), 8.79 (d, J = 9.3 Hz, 1H, NH); ESI-TOF-MS for C26H26N6O8:
(MH+) calcd: 551.18, found: 551.20.
4.6. Calculation of the pseudo-first order kinetics constant (kobs
)
The pseudo-first order kinetics constant (kobs) was obtained
from the slope of the log plot of the time-dependent concentration
of umbelliferone.
Acknowledgment
This work was supported in part by the Grants-in-Aid for Scien-
tific Research from the Ministry of Education, Culture, Sports,
Science and Technology, Japan to S.N. (No. 26810090) and T.M.
(25248038 & 15H01402). T.T. acknowledges the Japan Society for
the Promotion of Science for the fellowship (No. 15J09936).
4.3.6. Synthesis of 50-deoxy-50-(umbelliferyl butylate)amidoadenosine
(Umb-Ado) 7
A solution containing compound 6 (20 mg, 0.036 mmol) was
stirred in 50% TFA/H2O and after 48 h it was purified by HPLC (col-
umn: 5C18-AR-II 20 mm ꢀ 150 mm/mobile phase 5% acetic acid
with 24–48% acetonitrile) to give compound 7 (0.008 mmol,
A. Supplementary material
Supplementary data (pH dependence of extinction coefficient of
p-nitrophenol (Table S1), summary of the acceleration ratio for the
reaction rate (kobs) in the first screening (Table S2), binding mode
for the ATP-binding RNP receptor and adenosine (Fig. S1), time
dependent spectra of Umb-Ado in the buffer (Fig. S2), autoradio-
grams of the gel shift assay to confirm the complex formation
of RNP (Fig. S3), standard curve for the fluorescent intensity of
1
24%). H NMR (300 MHz, CDCl3) d 2.75–2.81 (m, 2H, H90), 2.95–
3.06 (m, 2H, H80), 3.34–3.38 (m, 3H, H40 and H50), 4.29 (d,
J = 2.57, 1H, H30), 4.75 (t, J = 6.2 Hz, 1H, H20), 5.81 (d, J = 6.6 Hz,
1H, H10), 6.42 (d, J = 9.4 Hz, 1H, Ar-H), 7.10 (dd, J = 8.4, 2.2 Hz,
1H, Ar-H), 7.17 (d, J = 1.8 Hz, 1H, Ar-H), 7.55 (d, J = 8.4 Hz, 1H,